UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

Breast cancer research and treatment, 2011-10, Vol.129 (3), p.939-946

2011

Volltextzugriff (PDF)

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Clinical cancer research, 2024-05, Vol.30 (10), p.2160-2169

2024

Volltextzugriff (PDF)

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

Breast cancer research and treatment, 2016-04, Vol.156 (3), p.507-515

2016

Volltextzugriff (PDF)

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study

Investigational new drugs, 2019-02, Vol.37 (1), p.98-108

2019

Volltextzugriff (PDF)

Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor

Clinical cancer research, 2022-03, Vol.28 (6), p.1107-1116

2022

Volltextzugriff (PDF)

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease

Breast cancer research : BCR, 2023-06, Vol.25 (1), p.67-67, Article 67

2023

Volltextzugriff (PDF)

Chemotherapy for gastric cancer

World journal of gastroenterology : WJG, 2006-01, Vol.12 (2), p.204

2006

Volltextzugriff (PDF)

A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome

Clinical cancer research, 2011-04, Vol.17 (7), p.2006-2013

2011

Volltextzugriff (PDF)

Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations

The oncologist (Dayton, Ohio), 2009-01, Vol.14 (1), p.1-11

2009

Volltextzugriff (PDF)

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia

Breast (Edinburgh), 2020-12, Vol.54, p.160-163

2020

Volltextzugriff (PDF)

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

Breast cancer research and treatment, 2014-02, Vol.143 (3), p.507-515

2014

Volltextzugriff (PDF)

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11419

2023

Volltextzugriff (PDF)

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

Breast cancer research and treatment, 2010-07, Vol.122 (1), p.169-176

2010

Volltextzugriff (PDF)

BRCA1 Alternative splicing landscape in breast tissue samples

BMC cancer, 2015-04, Vol.15 (1), p.219-219, Article 219

2015

Volltextzugriff (PDF)

Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease

Translational research : the journal of laboratory and clinical medicine, 2015-12, Vol.166 (6), p.783-787

2015

Volltextzugriff (PDF)

Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

Journal of thoracic oncology, 2012-12, Vol.7 (12), p.1823-1829

2012

Volltextzugriff (PDF)

Irinotecan in the treatment of elderly patients with advanced colorectal cancer

Critical reviews in oncology/hematology, 2008-12, Vol.68 (3), p.250-255

2008

Volltextzugriff (PDF)

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

Breast cancer research and treatment, 2017-02, Vol.162 (1), p.181-189

2017

Volltextzugriff (PDF)

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Clinical cancer research, 2018-04, Vol.24 (8), p.1845-1852

2018

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(110)

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

Female
(99)
Science & Technology
(95)
Life Sciences & Biomedicine
(91)
Oncology
(69)
Middle Aged
(65)
Adult
(58)
Aged
(52)
Breast Cancer
(50)
Breast Neoplasms - Pathology
(45)
Breast Neoplasms - Drug Therapy
(43)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Treatment Outcome
(26)
Breast Neoplasms - Genetics
(22)
Aged, 80 And Over
(21)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(21)
Chemotherapy
(21)
Neoplasm Metastasis
(18)
Male
(17)
Tumors
(17)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study

Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease

Chemotherapy for gastric cancer

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome

Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

BRCA1 Alternative splicing landscape in breast tissue samples

Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009‐05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis

Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype

Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease

Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

Irinotecan in the treatment of elderly patients with advanced colorectal cancer

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Aktive Filter

Suchergebnisse filtern